Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Cash from Financing Activities (2016 - 2024)

Historic Cash from Financing Activities for Avricore Health (AVCRF) over the last 11 years, with Q4 2024 value amounting to $12527.4.

  • Avricore Health's Cash from Financing Activities changed N/A to $12527.4 in Q4 2024 from the same period last year, while for Dec 2024 it was $41057.4, marking a year-over-year change of. This contributed to the annual value of $41340.6 for FY2024, which is 3124.18% up from last year.
  • Avricore Health's Cash from Financing Activities amounted to $12527.4 in Q4 2024.
  • In the past 5 years, Avricore Health's Cash from Financing Activities registered a high of $2.0 million during Q1 2021, and its lowest value of -$10686.4 during Q1 2024.
  • For the 5-year period, Avricore Health's Cash from Financing Activities averaged around $226056.5, with its median value being $28848.2 (2020).
  • As far as peak fluctuations go, Avricore Health's Cash from Financing Activities skyrocketed by 2933930.91% in 2021, and later tumbled by 15253.47% in 2024.
  • Quarter analysis of 5 years shows Avricore Health's Cash from Financing Activities stood at $473420.0 in 2020, then plummeted by 87.11% to $61042.5 in 2021, then soared by 159.33% to $158302.7 in 2022, then crashed by 92.95% to $11166.8 in 2023, then grew by 12.18% to $12527.4 in 2024.
  • Its Cash from Financing Activities stands at $12527.4 for Q4 2024, versus $38485.3 for Q3 2024 and $731.14 for Q2 2024.